Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis.

Vadiei K, Troy S, Korth-Bradley J, Chiang ST, Zimmerman JJ.

J Clin Pharmacol. 1997 Jul;37(7):610-7.

PMID:
9243354
2.

Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function.

Vadiei K, O'Rangers EA, Klamerus KJ, Kluger J, Kazierad DJ, Leese PT, Chow MS, Zimmerman JJ.

J Clin Pharmacol. 1996 Aug;36(8):720-7. Erratum in: J Clin Pharmacol 1997 Jan;37(1):73-5.

PMID:
8877676
3.
4.

Disposition of intravenous amiodarone in subjects with normal and impaired renal function.

Ujhelyi MR, Klamerus KJ, Vadiei K, O'Rangers E, Izard M, Neefe DL, Zimmerman JJ, Chow MS.

J Clin Pharmacol. 1996 Feb;36(2):122-30.

PMID:
8852388
5.

Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.

Vadiei K, Siddik ZH, Khokhar AR, al-Baker S, Sampedro F, Perez-Soler R.

Cancer Chemother Pharmacol. 1992;30(5):365-9.

PMID:
1505075
6.

Role of vascular congestion in cisplatin-induced acute renal failure in the rat.

Luke DR, Vadiei K, Lopez-Berestein G.

Nephrol Dial Transplant. 1992;7(1):1-7.

PMID:
1316576
7.

Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine.

Vadiei K, Lopez-Berestein G, Perez-Soler R, Luke DR.

Drug Metab Dispos. 1991 Nov-Dec;19(6):1147-51.

PMID:
1687023
8.

Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis.

Wasan KM, Vadiei K, Luke DR, Keyhani A, White RA, McQueen TJ, Mehta R, Lopez-Berestein G.

Antimicrob Agents Chemother. 1991 Oct;35(10):2046-8.

9.

Attenuation of amphotericin-B nephrotoxicity in the candidiasis rat model.

Luke DR, Wasan KM, Verani RR, Brunner LJ, Berens KL, Vadiei K, Lopez-Berestein G.

Nephron. 1991;59(1):139-44.

PMID:
1944727
10.

Circadian variation in renal function of the obese rat.

Luke DR, Wasan KM, Vadiei K.

Ren Physiol Biochem. 1991;14(1-2):71-80.

PMID:
1706108
11.

Disposition and toxicity of amphotericin-B in the hyperlipidemic Zucker rat model.

Vadiei K, Lopez-Berestein G, Luke DR.

Int J Obes. 1990 Jun;14(6):465-72.

PMID:
2401582
12.

Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker rat.

Berens KL, Vadiei K, Brunner LJ, Wasan KM, Luke DR.

Biopharm Drug Dispos. 1990 Apr;11(3):197-206.

PMID:
2328306
13.

Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats.

Wasan KM, Vadiei K, Lopez-Berestein G, Luke DR.

J Infect Dis. 1990 Mar;161(3):562-6.

PMID:
2313133
14.

Bioavailability assessment of cyclosporine in the rat. Influence of route of administration.

Luke DR, Brunner LJ, Vadiei K.

Drug Metab Dispos. 1990 Mar-Apr;18(2):158-62.

PMID:
1971566
15.

Pentoxifylline in amphotericin B toxicity rat model.

Wasan KM, Vadiei K, Lopez-Berestein G, Verani RR, Luke DR.

Antimicrob Agents Chemother. 1990 Feb;34(2):241-4.

16.

Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantation.

Luke DR, Beck JE, Vadiei K, Yousefpour M, LeMaistre CF, Yau JC.

J Clin Pharmacol. 1990 Feb;30(2):163-9.

PMID:
2312769
17.

Impact of time and feeding habits on lipid levels in Zucker obese rats.

Brunner LJ, Wasan KM, Vadiei K, Berens KL, Luke DR.

Prog Clin Biol Res. 1990;341B:195-201.

PMID:
2217311
18.

Lack of circadian variation in renal function in the obese rat: influence of continuous food and water intake.

Luke DR, Wasan KM, Vadiei K.

Prog Clin Biol Res. 1990;341A:131-6. No abstract available.

PMID:
2217226
19.

Isolation-induced renal functional changes in rats from four breeders.

Vadiei K, Berens KL, Luke DR.

Lab Anim Sci. 1990 Jan;40(1):56-9.

PMID:
2153862
20.

Cyclosporine pharmacokinetics and effect in the type I diabetic rat model.

Brunner LJ, Iyer LV, Vadiei K, Weaver WV, Luke DR.

Eur J Drug Metab Pharmacokinet. 1989 Oct-Dec;14(4):287-92.

PMID:
2699289
21.

Effects of pentoxifylline in experimental acute renal failure.

Vadiei K, Brunner LJ, Luke DR.

Kidney Int. 1989 Sep;36(3):466-70.

22.

Prevention of cyclosporine-induced nephrotoxicity with pentoxifylline.

Brunner LJ, Vadiei K, Iyer LV, Luke DR.

Ren Fail. 1989;11(2-3):97-104.

PMID:
2516344
23.

Cyclosporine disposition in the hyperlipidemic rat model.

Brunner LJ, Vadiei K, Luke DR.

Res Commun Chem Pathol Pharmacol. 1988 Mar;59(3):339-48.

PMID:
3363220
24.

Time-dependent pharmacokinetics and toxicity of cyclosporine.

Luke DR, Vadiei K, Brunner LJ.

Chronobiol Int. 1988;5(4):353-62.

PMID:
3069229

Supplemental Content

Loading ...
Support Center